Hyro was founded in 2018, with roots at the Cornell Tech studio, to solve a chronic problem in healthcare access: patients struggle to reach their providers, and call centers and front-desk staff are overwhelmed by repetitive, high-volume requests. Hyro builds conversational AI agents that automate these interactions across digital and voice channels, letting patients register, find care, schedule appointments, get routed to the right department, and manage prescriptions without waiting on hold or navigating clunky phone trees.
A key differentiator for Hyro is its emphasis on 'responsible' AI built for the stringent requirements of healthcare. Its platform is designed to be explainable and to minimize hallucinations, an essential property when handling sensitive patient communication, and it maintains compliance with HIPAA and other healthcare standards. Rather than a black-box chatbot, Hyro positions its agents as adaptive systems that can be trusted to operate at scale across clinical and administrative use cases.
Hyro's agents can accurately resolve up to 85% of routine patient interactions, deflecting calls and messages away from human staff while improving the patient experience. The platform is deployed at scale across more than 45 leading health systems, including large organizations such as Sutter Health, Tampa General Hospital, Prisma Health, and Piedmont Healthcare, giving Hyro a substantial real-world footprint in a market where trust and reliability are paramount.
In October 2025, Hyro announced a $45 million strategic growth round led by Healthier Capital, with participation from Norwest, Define Ventures, and other existing investors, plus strategic investments from its long-time client Bon Secours Mercy Health and from ServiceNow Ventures. The round, which doubled the company's valuation and brought total funding to roughly $95 million, came just ten months after its prior raise and funds development of administrative, operational, and clinical AI agents.
Led by co-founder and CEO Israel Krush, Hyro is positioned in the fast-growing market for healthcare conversational AI, where the combination of compliance, reliability, and measurable call deflection drives adoption among large health systems.